Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Combination of targeted biopsy and systematic biopsy

Before prostate biopsy, the MR images of patients were independently reviewed by MRI-AI and urogenital radiologists. Then the images with suspicious lesions highlighted by MRI-AI and urogenital radiologists. Urologists conducted targeted biopsies for all suspicious lesions and systematic biopsies. Biopsies were performed under the guidance of transrectal ultrasound (TRUS) through the transrectal or transperineal route.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER